Large-scale testing (Phase 3)Study completedNCT05375929What this trial is testingLearn About Abrocitinib Tablets in People With Atopic Dermatitis in IndiaWho this might be right forAtopic Dermatitis Pfizer 200
Testing effectiveness (Phase 2)Study completedNCT02900131What this trial is testingEfficacy, Safety and Dose Finding Trial of Topical Jaungo Application in Atopic Dermatitis PatientsWho this might be right forDermatitis, Atopic Kyung Hee University Hospital at Gangdong 34
Not applicableUnknownNCT03471819What this trial is testingSerotonin Levels in Atopic Dermatitis PatientsWho this might be right forDermatologic Disease Assiut University 50
Not applicableNot Yet RecruitingNCT03664271What this trial is testingEducational Eczema Video InterventionWho this might be right forEczema Boston Children's Hospital 168
Large-scale testing (Phase 3)Study completedNCT02595073What this trial is testingClinical Study to Evaluate the Efficacy and Safety of Desoximetasone (DSXS) With Atopic DermatitisWho this might be right forAtopic Dermatitis Sun Pharmaceutical Industries, Inc. 124
Post-approval studies (Phase 4)Study completedNCT00180141What this trial is testingElidel-Study: Elidel in Patients With Atopic DermatitisWho this might be right forAtopic Dermatitis Technische Universität Dresden 24
Post-approval studies (Phase 4)Study completedNCT00096954What this trial is testingA Prospective, Randomized, Double-Blind Study of the Efficacy of Omalizumab (Xolair) in Atopic Asthmatics With Good Lung Capacity Who Remain Difficult to Treat (EXACT)Who this might be right forAsthma Genentech, Inc. 333
Not applicableStudy completedNCT04174651What this trial is testingStress-induced Scratching in Healthy and ADWho this might be right forHealthyAtopic Dermatitis University of Miami 8
Not applicableLooking for participantsNCT05575882What this trial is testingAnti-relapse Efficacy and Tolerance Assessment of a Cosmetic Cream for Very Dry, Irritated to Atopic Sensitive Skin.Who this might be right forAtopic DermatitisEczema, Atopic NAOS Argentina S.A. 100
Early research (Phase 1)Study completedNCT00725582What this trial is testingStudy Evaluating the Effect of IMA-026 on Allergen-Induced Late Asthma Response in Mild AsthmaWho this might be right forAsthma Wyeth is now a wholly owned subsidiary of Pfizer 24
Testing effectiveness (Phase 2)Study completedNCT00410280What this trial is testingStudy Evaluating the Effects of IMA-638 on Allergen-Induced Airway Responses in Subjects With Mild Atopic AsthmaWho this might be right forAsthma Pfizer 30
Post-approval studies (Phase 4)Study completedNCT01093469What this trial is testingComparing Aquaphor to Atopiclair and EpiCeram in Children With Mild to Moderate Atopic DermatitisWho this might be right forAtopic Dermatitis Wake Forest University Health Sciences 39
Not applicableLooking for participantsNCT06362629What this trial is testingAI App for Management of Atopic DermatitisWho this might be right forAtopic DermatitisArtificial Intelligence West China Hospital 232
Post-approval studies (Phase 4)Study completedNCT00568412What this trial is testingA Clinical Study in Children and Adolescents With Mild to Moderate Atopic DermatitisWho this might be right forMild to Moderate Atopic Dermatitis Bayer 80
Not applicableStudy completedNCT03251157What this trial is testingDietary Intake in Adults From the GA2LEN Folow-up SurveyWho this might be right forAsthmaLung Function DecreasedFood Allergy+4 more Johns Hopkins Bloomberg School of Public Health 3,500
Large-scale testing (Phase 3)Study completedNCT04040192What this trial is testingEvaluate Long-Term Maintenance Treatment With Once Daily Crisaborole Ointment 2% in Pediatric and Adult Participants With Mild-to-Moderate Atopic DermatitisWho this might be right forAtopic Dermatitis Pfizer 620
Post-approval studies (Phase 4)Study completedNCT05436535What this trial is testingLongitudinal Endotyping Of Atopic Dermatitis Through Transcriptomic Skin AnalysisWho this might be right forAtopic Dermatitis National Institute of Allergy and Infectious Diseases (NIAID) 433
Large-scale testing (Phase 3)Study completedNCT00691262What this trial is testingStudy to Evaluate the Response to Treatment and Safety of 0.03% Tacrolimus (FK506) Ointment Administered in Pediatric Patients With Moderate to Severe Atopic DermatitisWho this might be right forDermatitis, Atopic Astellas Pharma Inc 166
Not applicableActive Not RecruitingNCT03428646What this trial is testingStudy of Patients Receiving DUPIXENT® for Atopic Dermatitis (AD)Who this might be right forDermatitis, Atopic Regeneron Pharmaceuticals 858
Large-scale testing (Phase 3)UnknownNCT05676242What this trial is testingA Phase III Extended Clinical Trial of Jaktinib Hydrochloride Tablets in the Treatment of Moderate and Severe Atopic DermatitisWho this might be right forAtopic Dermatitis Suzhou Zelgen Biopharmaceuticals Co.,Ltd 400